MedPath

Effect of unilateral conductive hearing loss and its therapy on neuronal activity of the auditory sys-tem – a PET, MRI/DMI, fNIRS and microphenomenologic study

Not Applicable
Conditions
H90.1
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
Registration Number
DRKS00033812
Lead Sponsor
niklinik Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
160
Inclusion Criteria

Study group 1:
- Diagnosis with unilateral conductive hearing loss
- Treatment with a bone-conductive device or an active middle ear implant
Study group 2:
- Diagnosis with unilateral conductive hearing loss
- No treatment with a bone-conductive device or an active middle ear implant
Study group 1 and 2:
- age = 18 years
- right handed
- German at at least B1 level

Exclusion Criteria

- Relevant neurological or psychiatric illness
- Circumstances and illnesses that suggest insufficient compliance with the PET or fMRI examination
- Pregnancy, breastfeeding
- Poorly controlled diabetes mellitus
- Study-related radiation exposure from previous study participation
- Relevant ophthalmological diseases
- Participants do not agree to the communication of incidental findings.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Study groups 1 und 2:<br>Neuronal activity of the auditory cortex during acoustic, visual and vibrotactil stimulation (fNRIS, functional near-infrared spectroscopy)
Secondary Outcome Measures
NameTimeMethod
Study group 1<br>- Glucose uptake in the primary auditory coretx and inferior colliculus<br>- interhemispheric connectivity of the primary auditory coretx
© Copyright 2025. All Rights Reserved by MedPath